Westpac announces Michael Rowland as CFO | ASX Market Update

2 min read | July 14, 2020 09:45 PM AEST | By Team Kalkine Media

Australian clinical stage immuno-oncology firm, Imugene Limited (ASX:IMU) has received approval from Human Research Ethics Committee (HREC) to initiate a Phase I clinical trial of PD1-Vaxx in Australia. A comprehensive cancer hospital situated in Sydney, Chris O’Brien Lifehouse is the first one to attain ethics approval. Further clinical sites will be opened in Australia as well as the US, following an FDA (Food and Drug Administration) investigational new drug (IND). Imugene notified that the ethics approval process represents the first independent review of PD1-Vaxx pre-clinical efficacy and safety data. As at 12:51 PM AEST, IMU traded at $0.035, with a rise of ~3%.

ABS data revealed that total payroll jobs in June end were still 5.7% below mid-March when Australia confirmed its 100th coronavirus case. Payroll jobs worked by females improved with 0.8% increase in June compared to 0.1% fall for males. Job losses for people under 20 were about 23% by mid-April but lowered to around 5% by June end. Industries employing the largest proportions of people aged under 20, Accommodation and food services and Retail trade witnessed further rise in payroll jobs of 8.9% and 1.6%, respectively in June. Head of labor statistics at ABS stated that total payroll jobs have increased by 3.3% and about 35% of payroll jobs initially lost had been retained by June end.

Westpac has ended a near six-month job search to replace its chief financial officer by appointing KPMG partner Michael Rowland to the top role. Mr Rowland will take up the position later this year, closing a recruitment drive sparked by Westpac’s 2019 AUSTRAC scandal that thrust then CFO Peter King to take helm of the country’s second largest bank. Mr Rowland had held previous senior executive positions at rival bank ANZ, including CFO of its institutional and wealth divisions. He was also the previous CFO of ING Australia from 2002 to 2004. Gary Thurby will continue as Westpac’s acting CFO until Mr Rowland’s regulatory approval is finalised.

#ABS #ASX #IMU #Kalkine


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.